MRGN Advisors - Geneva

  • Home
  • About
  • Partners
  • Capabilities
  • News
  • Contact
  • Home
  • About
  • Partners
  • Capabilities
  • News
  • Contact

Alma Bio Therapeutics welcomes Dr. Pierre A. Morgon as member of the board of directors

3/11/2017

 
Dr. Morgon, a 30-year pharma industry veteran, will bring vast experience and business expertise to Alma as it progresses towards the clinical trial of a therapeutic drug to cure autoimmune diseases.

Lyon, France, September 26, 2017 – Alma Bio Therapeutics SAS (Alma), a pioneer of a new class of curative therapies that harnesses the patient’s own immune system to treat autoimmune diseases, announces today that Dr. Pierre A. Morgon will join its board of directors. He will take an active role in Alma’s Series A financing, which will commence
shortly.

​Alma has developed a therapeutic entity aimed at treating the underlying cause of uncontrolled inflammation in autoimmune diseases. While its therapeutic entity, a DNA plasmid, has shown strong potential for treating many autoimmune diseases, the company is targeting Crohn’s disease, one of the two major types of Inflammatory Bowel Disease (IBD), as its first clinical application. There are no available curative treatments for IBD, a chronic debilitating disease that affects the gastrointestinal tract.

Read More

    MRGN Advisors

    MRGN Advisors 
    Rue du Mont-Blanc 4    
    Case postale 2067    
    CH - 1211 Genèva 1 
    Switzerland

    Archives

    October 2020
    September 2020
    November 2019
    July 2019
    February 2019
    February 2018
    November 2017
    February 2017
    January 2017
    January 2016
    December 2015
    November 2015
    June 2015
    January 2015
    June 2014
    May 2014
    April 2014
    March 2014
    January 2014
    November 2013
    October 2013
    September 2013
    June 2013
    January 2012

    Categories

    All

    RSS Feed

MRGN Advisors
The company is a healthcare consultancy established in 2015
Rue du Cendrier 15  |  Case postale 2067  |  CH - 1211 Genève 1   |  ​Switzerland  |  info@mrgnadvisors.com
Création de site Internet